Related Experiment Videos
Gastroesophageal reflux disease. Selecting optimal therapy
1Oklahoma Foundation for Digestive Research, University of Oklahoma Health Center, Oklahoma City 73104.
Postgraduate Medicine
|February 1, 1994
Summary
Understanding gastroesophageal reflux disease (GERD) pathophysiology guides therapy. Mild GERD may improve with lifestyle changes and antacids, while severe cases may need H2 blockers, other medications, or surgery.
Area of Science:
- Gastroenterology
- Internal Medicine
- Pharmacology
Background:
- Gastroesophageal reflux disease (GERD) is a common condition with varied pathophysiology.
- Effective management requires understanding the underlying mechanisms of reflux.
Purpose of the Study:
- To outline the relationship between GERD pathophysiology and therapeutic strategies.
- To provide guidance on selecting appropriate treatments based on disease severity and type.
Main Methods:
- Review of current medical literature on GERD pathophysiology and treatment.
- Analysis of traditional, medical, and surgical management options.
- Consideration of pharmacological mechanisms of action for different drug classes.
Main Results:
- Conservative measures (lifestyle changes, antacids) are foundational for mild GERD.
- Prescription histamine2 (H2) receptor blockers are primary medical treatments.
- Prokinetic agents and H+,K(+)-ATPase inhibitors are options for refractory GERD.
- Antireflux surgery is reserved for a small subset of patients.
- Over-the-counter H2 blockers could enhance conservative therapy.
Conclusions:
- Tailoring GERD therapy to its pathophysiology and severity is crucial for optimal outcomes.
- A stepwise approach, from conservative measures to pharmacotherapy and surgery, is recommended.
- Future availability of over-the-counter H2 blockers may broaden conservative management options.